Skip to content
Screener

Exelixis EXEL Operating Lease Liabilities

Operating Lease Liabilities at other companies

Kura Oncology logo
Kura OncologyKURA
$13.24M+68.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$29.96M-12.2%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Opko Health logo
Opko HealthOPK
$33.98M-8.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$47.3M+22.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$1.41M+1,024%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$12.93B+27.4%
Enterprise value$12.82B+26.1%
P/E15×-1.8×
P/S5.3×+0.8×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemJune 30, 2026December 31, 2025
Accrued collaboration liabilities25,09622,783
Other current liabilities102,662125,382
Total current liabilities361,927405,644
Non-current operating lease liabilities165,929173,038
Other non-current liabilities122,616104,422
Total liabilities650,472683,104
Commitments and contingencies (Note 11)
Stockholders’ equity:

Item 1. Financial Statements.

FAQ

What is Exelixis's operating lease liabilities?
Exelixis (EXEL) reported operating lease liabilities of $165.93M in Q2 2026.
How has Exelixis's operating lease liabilities changed year-over-year?
Exelixis's operating lease liabilities decreased by 7.7% year-over-year, from $179.84M to $165.93M.
What is the long-term trend for Exelixis's operating lease liabilities?
Over 5 years (2020 to 2025), Exelixis's operating lease liabilities has grown at a 28.7% compound annual growth rate (CAGR), from $49.09M to $173.04M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Ask your AI about Exelixis's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude